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Abstract: Cyanobacteria hold significant potential as industrial biotechnology (IB) platforms for
the production of a wide variety of bio-products ranging from biofuels such as hydrogen, alcohols
and isoprenoids, to high-value bioactive and recombinant proteins. Underpinning this technology,
are the recent advances in cyanobacterial “omics” research, the development of improved genetic
engineering tools for key species, and the emerging field of cyanobacterial synthetic biology. These
approaches enabled the development of elaborate metabolic engineering programs aimed at creating
designer strains tailored for different IB applications. In this review, we provide an overview of the
current status of the fields of cyanobacterial omics and genetic engineering with specific focus on the
current molecular tools and technologies that have been developed in the past five years. The paper
concludes by giving insights on future commercial applications of cyanobacteria and highlights the
challenges that need to be addressed in order to make cyanobacterial industrial biotechnology more
feasible in the near future.
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1. Introduction
Cyanobacteria represent an extremely diverse, yet highly specialised group of prokaryotic
organisms found in a wide range of environmental habitats [1]. Cyanobacteria have been regarded
as attractive laboratory models for genetic studies of fundamental processes such as carbon and
nitrogen fixation [2,3]. This is mainly because they are amenable to genetic manipulation by the
techniques already developed for the intensively studied heterotrophic bacteria such as E. coli [4]. The
field of molecular biology for cyanobacteria has witnessed enormous development in the past two
decades going from almost the absence of any knowledge in the mid-seventies to the development
of transformation systems in the eighties [5,6]. In the nineties, this field turned into a full-fledged
unique and promising field of research [7–9] due to the determination of the full sequence of the
cyanobacterium Synechocystis PCC 6803 in 1996 [10]. Nowadays, the full genomic sequences of 128
cyanobacterial strains are available, hence making their genetic manipulation even more feasible [11].
Recently, a lot of attention has been directed towards the development of cyanobacteria
as industrial biotechnology (IB) platforms by employing bioengineering and synthetic biology
tools [12–15]. Cyanobacteria have great potential in the production of renewable fuels, various
chemicals and nutritional products. A list of various drop-in biofuels that have been produced in
engineered cyanobacteria are detailed in [16,17] and Table 1. The fact that engineered cyanobacteria
have the potential to produce compounds that act as drop-in fuels that do not require additional
refining or chemical modification for use in an engine [18], and that their composition can be tailored
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by genetic manipulation, make cyanobacterial-produced fuel molecules excellent options as future
fungible fuels [6]. In a recent study, the combustion and emissions of terpenes in a diesel engine were
examined with a view to their biological production in cyanobacteria [19]. The study highlighted the
potential of genetically engineering the isoprenoid pathway of Synechocystis 6803 for the production of
isoprenoid-derived fuels that can act as drop-in fuels in diesel engines [19].
Table 1. Current reports of biofuel production in genetically engineered cyanobacteria. The number
of transgenes required is indicated, although in several cases additional genes were introduced to
increase productivity.
Fuel Molecule Species Engineered No. of Genes Reference
Ethanol (C2H5OH) Synechocystis sp. PCC6803 2 [20]
Synechococcus elongatus PCC7942 2 [21]
Anabaena sp. PCC7120 Algenol Biofuels Company
1-Butanol (C4H9OH) Synechococcus elongatus PCC7942 5 [22]
Isobutanol (C4H9OH) Synechococcus elongatus PCC7942 5 [17]
Synechocystis sp. PCC6803 2 [23]
Ethylene (C2H4) Synechococcus elongatus PCC7942 1 [8,24]
Isobutyraldehyde (C4H8O) Synechococcus elongatus PCC7942 5 [17]
Isoprene (C5H8) Synechocystis sp. PCC6803 1 [16]
Free fatty acids (C10–C18) Synechocystis sp. PCC6803 5 [25]
Fatty alcohols (C16/C18) Synechocystis sp. PCC6803 1 [26]
n-alkanes (CnH2n) Synechococcus sp. PCC7002 2 Joule Unlimited Company
Thermosynechococcus elongatus BP-1 Joule Unlimited Company
Synechocystis sp. PCC6803 Joule Unlimited Company
Hydrogen (H2) Synechococcus elongatus PCC7942 1 [27]
Sesquiterpenes (C15H24) Synechocystis sp. PCC6803 [28]
Squalene Synechocystis sp. PCC6803 Inactivation of gene slr2089 [29]
Additionally, cyanobacteria are being optimised to overproduce numerous products of value [20].
For example, naturally occurring cyanobacterial phycobiliproteins are commonly used in fluorescent
tagging applications in research [21] in conjugation with monoclonal and polyclonal antibodies to make
fluorescent antibody reagents that are used for cell sorting [22]. Other natural products are used as food
dyes or pigments in cosmetics [23]. Some cyanobacterial strains are used as vectors for the delivery of
mosquitocidal toxins [21], while nitrogen-fixing strains are commonly used as natural fertilisers [23].
Chemical products such as fish growth hormones [21], polyhydroxyalkanoates (PHA’s) [22,24] and
polyunsaturated fatty acids (PUFA) [25] have been produced from genetically engineered cyanobacteria.
Synechococcus has been genetically engineered for the heterologous expression of a single gene (efe)
from Pseudomonas syringae that led to the successful synthesis of ethylene [8], one of the most important
building blocks in synthetic chemical industry [26]. Furthermore, acetone was recently produced by
modified Synechocystis 6803 with a reported yield of 36.0 mg/L [27]. A summary of some of the various
cyanobacterial products can be found in Figure 1, and [28].
Although synthetic biology tools have contributed significantly to unlocking cyanobacteria’s
potential for these functions, these tools are still far behind those established for S. cerevisiae and
E. coli [29]. Nevertheless, in recent years, there have been significant advances in cyanobacterial
strain improvement using genetic engineering and synthetic biology [30]. It is worth mentioning
that most of the efforts for developing genetic engineering tools have been aimed at model or
heavily studied cyanobacterial strains such as the filamentous, nitrogen-fixing Anabaena sp. strain
PCC 7120 [31–33], and the naturally competent Synechococcus 7942 [34–37], Synechococcus 7002 [38–44]
and Synechocystis 6803 [16,45–52]. This review discusses the recent developments in the field of
cyanobacterial genetic modification in the past five years and how these tools can be employed
to increase the efficiency of cyanobacteria in industrial biotechnology applications.
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Figure 1. Schematic overview of different biotechnological uses and potential products of genetically 
engineered cyanobacteria. Items under “Photosynthetic system” refer to native products that are 
directly linked to the functions within the thylakoid membrane. The photosynthetic system diverges 
electrons from two primary reactions in the thylakoids directly to H2. The products of the Calvin cycle 
(carbohydrates, proteins, lipids and fatty acids) lead to the formation of various biofuel options. The 
white arrow indicates products under light conditions, while the black arrow indicates products 
under dark conditions. Items under “Biomass” refer to uses of the entire biomass and heterogeneous 
products through genetic engineering. PHA's: Polyhydroxyalkanoates, PUFA: Polyunsaturated fatty 
acids, BTL: bipolar tetraether lipids. All the arrows indicate the relative utilization or production of 
an item. The double ended arrow between “Biomass” and “Photosynthetic system” implies that 
biomass is a result of the photosynthetic system. 
2. Cyanobacterial “Omics” 
The model organism Synechocystis sp. PCC 6803 (hereafter Synechocystis 6803) in 1996 was the 
first photosynthetic organism to have its genome sequenced [53]. Advances in sequencing 
technologies and the decrease in their costs have led to more and more strains of cyanobacteria being 
fully sequenced [54,55]. To date, CyanoBase (http://genome.microbedb.jp/cyanobase), one of the 
most widely used databases for cyanobacterial strains, contains 39 completed cyanobacterial genome 
sequences while the National Centre for Biotechnological Information (NCBI) 
(http://www.ncbi.nlm.nih.gov) contains 111 sequenced strains. The availability of these genomes has 
a huge impact on the directed molecular biology work that can be carried out. Genomic sequences 
can be used to identify pathways useful for the production of biotechnologically relevant compounds. 
For example, a comparison between the genomic sequences of alkane-producing and non-producing 
cyanobacteria has led to the identification of the alkane-producing pathway [56]. 
Microarray data measures the level of expression of a large number of genes within a genome. 
There is a large amount of microarray data for Synechocystis 6803 looking at levels of gene expression 
in different conditions that can be found in the databases Gene Expression Omnibus (GEO) [57], 
ArrayExpress [58] and Kyoto Encyclopedia of Genes and Genomes (KEGG) [59]. Although a lot of 
microarray data is on the two main model species, Synechocystis 6803 and Synechococcus elongatus 
PCC7942, there is also data on other cyanobacteria on the GEO database such as Prochlorococcus 
marinus MED4 and Nostoc punctiforme PCC73102. Recently, RNA-sequencing has started being used 
to study the transcriptome of cyanobacteria. For instance, RNA-sequencing transcriptomic analysis 
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analysis of the diazotrophic Anabaena sp. strain 90 revealed the upregulation of phosphorous
transport and assimilation genes (pho regulon) during phosphorous deprivation in algal blooms [60].
RNA-sequencing was used to identify genes in Synechocystis 6803 that could be engineered to
make ethanol-resistant strains [61]. In another study, RNA-sequencing transcriptomic analysis
revealed a gene encoding a phosphatase protein (slr1860) that promoted ethanol tolerance in
Synechocystis 6803 [62].
Metabolomics, transcriptomics and proteomics have been used to improve biofuel tolerances
in Synechocystis 6803, which provided valuable correlations between genes, protein expression and
production titers of different biotechnological products [63,64]. In a study on isoprene production
from Synechocystis 6803, the metabolomic and transcriptomic profiles were analysed under metabolic
stress [64]. The metabolomic profile suggested that the limiting factor of isoprene production
under stress might be due to an insufficient precursor level, while the transcriptome revealed an
upregulation of RNA characteristic of acclimation to stress [64]. Tolerance of Synechocystis 6803
towards other products, like butanol, was investigated using transcriptomics and it was revealed
that the gene encoding HspA, a small heat shock protein, was induced when Synechocystis 6803 was
grown in the presence of butanol. By overexpressing this gene, Synechocystis was more tolerant to
butanol [65]. Proteomics analysis identified genes in Synechocystis 6803 that are induced in response to
hexane, butanol and ethanol [66–68]. The information gained can be used to engineer tolerance into
Synechocytsis 6803 in the hope of optimizing the production of biofuels and other toxic products in this
model organism. Such studies can later be expanded to include other cyanobacterial strains.
Over the past decade, Synechocystis 6803 metabolism has been modeled [69–79] to understand and
improve cyanobacterial biofuel production. In 2009, the first genome-scale model of Synechocystis 6803
to predict the effect of biofuel production was produced [80]. The in silico predictions introducing an
ethanol-producing pathway into Synechocystis 6803 matched the experimental data [80]. This represents
a good example of how transcriptomics and proteomics can assist in a more directed research approach
that can immensely help in saving time. Recently, a visual representation of the metabolic network
of Synechocystis 6803 called FAME was produced (http://f-a-m-e.org/synechocystis/), which can
incorporate experimental and computational data. FAME can be used as an aid to engineer the
metabolic pathway of Synechocystis 6803 for the production of a range of high value products and
biofuels [81].
Thus far, the majority of the transcriptomic, proteomic, metabolomic and systems biology data
available has focused on Synechocystis 6803 with little work performed on other cyanobacterial
strains. Although a genome-scale model has been produced for Synechoccocus 7942, [82] modeling the
nitrogen-fixing Cyanothece has already been attempted [83,84]. However, for cyanobacterial strains
without a well-annotated genome, producing a genome-scale model will be challenging.
3. Classical Genetic Engineering Technology
3.1. Cyanobacterial Transformation
Transformation of cyanobacteria has been thoroughly reviewed [4,22,85,86] and the methodology
has been well described [5,69]. The ability to transform cyanobacteria has been the drive for the
development of the molecular biology of these organisms and has been the basis of many of their
biotechnological applications [70]. Several cyanobacterial strains can be transformed with exogenously
added DNA [4] or can accept mobilised plasmid DNA from E. coli by conjugation [15]. Natural
transformation was first described for Synechococcus sp. strain PCC7942 [85] and hence is considered
the primary means for gene transfer in unicellular cyanobacteria [6]. Synechococcus and Synechocystis
species are among the few species that are known to be naturally transformable by exogenous DNA
with little known about why natural transformation has thus far been restricted to certain unicellular
cyanobacteria. This may be due to the presence of extracellular nucleases found in heterocyst-forming
filamentous cyanobacteria that results in the degradation of the incoming DNA [71]. The natural
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transformable nature of Synechococcus and Synechocystis species explains why a lot of focus has been
directed to the genetic engineering of these species. There are many factors that affect the frequency
and efficiency of transformation in cyanobacteria, which can vary between 10−3 and 10−8 [4]. These
include the used strain, the length, form and concentration of used DNA and also the method used for
transformation [72]. The optimum conditions for transformation of the model organism Synechocystis
sp. PCC 6803 are well described [72,73].
Since the discovery of cyanobacterial transformation in the 1970s, many techniques such as
electroporation and ultrasonic treatment have been developed and applied to several cyanobacterial
strains [70,73,74]. Electroporation has been used in the transformation of Anabaena sp., Synechococcus
sp., Synechocystis sp., Fremylla diplosiphon and Plectonema boryanum, [70,73,74]. Ultrasonic
transformation has been employed in the transformation of Synechocystis sp. [70,73,74]. It was
noted that, in Synechocystis 6803, exogenous DNA is integrated into the genome following natural
transformation by means of a well-established double homologous recombination system [72,73].
Cyanobacteria that use systems with homologous recombination mechanisms allow for more effective
gene modifications to wild-type genes [9]. This is true since gene replacement depends on homologous
recombination in order to replace a section of the recipient chromosome with a donor DNA that
contains a selectable marker [75]. Williams and Szalay [76], were the first to demonstrate homologous
recombination in cyanobacteria as a means of transformation, while Golden and Wiest, [77] were the
first to achieve homologous recombination in Anabaena. Although the transformation of cyanobacteria
was thoroughly investigated, very little is known on the mechanism by which DNA binds to the cell,
gets processed and subsequently transported across the membrane during transformation [10,72,78].
However, it is thought that type IV pili are involved in the uptake process [79,86]. Studying the effect
of deleting the gene(s) encoding type IV pili may give an insight into their role in the transformation
process. There is no doubt that the development of tools for the modification of cyanobacteria
will help accelerate cyanobacterial research which will ultimately improve its use for industrial
biotechnology applications. However, such improvements should not be restricted to the highly
investigated unicellular model organisms but extended to include strains with desired characteristics
such as those with fast growth rates, resistance to high temperatures and salinity, or resistance to
infection and nitrogen fixers to mention a few. This will increase the spectrum of cyanobacteria used
for industrial application purposes where characteristics such as the ones mentioned above are crucial.
3.2. Selectable Markers
It is essential to be able to select for rare transformant events amongst a large population of treated
cyanobacterial cells [4,11]. Systematic and efficient methods whereby successful transformants can be
identified and isolated are well established. Usually, host cells that contain the transferred DNA are
identified by transferring a gene whose product has the potential to inactivate an antimetabolite, such
as an antibiotic [22]. When cultured in the presence of the antimetabolite, only those cells to which the
gene (normally an antibiotic resistance cassette) has been transferred should grow. Since cyanobacteria
are Gram-negative bacteria, antibiotics and antibiotic-resistant genes that are known to be effective for
that group of bacteria have been extensively exploited [11].
Antibiotics used as selectable markers in cyanobacteria, in general, include neomycin and
kanamycin and the corresponding neomycin phosphotransferase (npt)-encoding genes from
transposons Tn5 and Tn903, and streptomycin and spectinomycin and the corresponding
aminoglycoside adenyltransferase (aadA)-encoding genes from Tn7 [87] and the omega interposon [88].
Bleomycin, although expensive, is sufficiently active to be cost effective with Anabaena 7120.
Chloramphenicol and chloramphenicol acetyl transferase (cat) have proven useful for unicellular
cyanobacteria [89] and Anabaena sp. strain 90 [90]. Nourseotricine has been reported recently
to be effective in a study on an RNA polymerase mutant of Synechocystis 6803 [91]. Antibiotics
such as tetracycline and rifampicin, which are light sensitive, are of much reduced usefulness for
cyanobacteria [21,22]. Other antibiotics with the same property include erythromycin [10], zeocin [92]
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and gentamicin [93]. However, gentamicin and erythromycin use in cyanobacteria induces oxidative
damage and should be used with caution [94,95].
Synechocystis 6803 specifically shows preference to some antibiotics. For example, it has
been reported that the transformants grew 4–6 days earlier in the plates containing kanamycin
than those containing chloromycetin [73]. Furthermore, the bacterial promoter and termination
sequences of kanamycin is recognised by Synechocystis 6803 and hence can be used without further
modifications [11]. A summary of the selectable markers (antibiotic resistance markers) suitable for use
in Synechocystis 6803 can be found in (Table 2) while the same combinations of antibiotics can be tested
with closely related species of cyanobacteria. By using a combination of antibiotic resistance cassettes,
multiple genes can be inactivated in a single cyanobacterial strain [96–98]. However, it should be noted,
when using multiple antibiotics resistance cassettes, that in some cases using one type of antibiotic
resistance cassette may lead to resistance towards another. For example, the cassette normally used for
spectinomycin resistance also results in streptomycin resistance. Therefore, it is necessary to introduce
the streptomycin resistance cassette before the spectinomycin resistance cassette [11].
Table 2. Selectable markers (antibiotic resistance markers) suitable for use in Synechocystis.
Selectable Marker Source Concentration (µg/mL) References
Chloramphenicol pBR325 5–150 [9,90]
Erythromycin pRL425 5–300 [9]
Kanamycin pUC4K (Tn 903) 5–500 [9,90]
Spectinomycin pHP45Ω 3–250 [6,9]
Neomycin Tn5 NA [32]
Streptomycin Tn7 NA [99]
Spectinomycin pHP45Ω (Tn7) 25 [90,99]
Zeocin - 25 [100]
Gentamicin - NA [101]
NA: not available.
3.3. Plasmid Expression Vectors
Plasmid vectors that are used in transformation of cyanobacteria can be classified into two main
groups [22]. The first group is the non-replicating plasmids or integrative plasmids and these cannot
replicate independently and would eventually be lost through successive cell divisions [26]. The other
group is commonly referred to as replicative plasmids, shuttle vectors or biphasic plasmids and are
capable of replication in both cyanobacteria and E. coli [22,26,37] as they most often contain replication
sequences from both E. coli and the cyanobacterial host [21]. Both integrative and replicative plasmids
have been developed for cyanobacteria and have their experimental uses. For example, the ideal
plasmid vector for transporting DNA that must either transpose (e.g., a transposon) or integrate (e.g.,
by homologous recombination) in order to be stably maintained are the integrative vectors [6,86].
These vectors are ideal for targeted mutagenesis in which the gene in the chromosome is replaced
by the mutated gene in the plasmid [6] or in which the cyanobacterial host needs to select for the
recombination of the plasmid into the chromosome [76]. It has been observed that none of the common
cloning vectors from E. coli seem to be able to replicate in cyanobacteria [4], presumably because
the colE1 origin of replication, carried on vectors such as pUC19, pBluescript and pGEM-T, are not
recognised by the DNA-replication machinery of cyanobacteria [86].
Replicative plasmids can be classified into two types: those that contain replicons of broad-host
range plasmids [102,103] and those derived from endogenous cryptic plasmids [37,104]. Replicative
plasmids carrying a variety of selectable markers have been constructed for cyanobacteria [6]. Examples
include the pFCLV 7 [89] and plasmids derived from RSF1010 (e.g., pSL1211, pPMQAK1 and
pFC1) [26,29,102]. Replicative plasmids that can replicate in multiple hosts (either broad or narrow
host range) have the potential to express an exogenous gene in numerous hosts [22]. Nevertheless,
most shuttle vectors for cyanobacteria are still not well characterised for their copy number [21], and
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the lack of shuttle vectors with a varied copy number puts limitations on the controlled expression of
heterologously expressed genes by selecting their copy number [99]. For example, the copy number
from plasmids derived from RSF1010 are ten per chromosome in E. coli cells and approximately 10–30
per cell in Synechocystis 6803 (~1–3 per chromosome) [102,103]. In a recent study, it was reported that
the GT wild-type strain contains 142 genome copies in the exponential phase and 42 genome copies in
the linear and stationary growth phase [105]. The copy number of other broad host-range plasmids
have not been quantified to date [29], which adds a limitation to their use. A recent review on shuttle
vectors used in various cyanobacterial hosts is presented in [26].
In terms of transformation efficiency, it has been reported that transformation of Synechocystis 6803
with plasmids obtained from Synechocystis 6803 cultures result in 10–20 times better transformation
rates than transformations done using bacterial plasmids, perhaps due to a compatible DNA
methylation pattern. Nevertheless, plasmids extracted from E. coli are routinely used as they are
much more convenient to prepare [106].
4. Emerging Synthetic Biology Technologies
Several tools for the model cyanobacterium Synechocystis 6803 have recently been
developed [12,100,101,107–109]. The existing methods for distinguishing viable from non-viable
cyanobacterial cells are either time-consuming (e.g., plating) or are not easy to prepare (e.g., fluorescent
staining). Recently, a cell-viability fluorescence assay was developed that provides a quick and simple
way of detecting viable from non-viable cells in a cyanobacterial culture [107]. In this method, red
chlorophyll fluorescence and an unspecific green autofluorescence were used for the differentiation
of viable and non-viable cells without the need of sample preparation. This method can be used to
monitor the fitness of cultures grown for novel industrial biotechnological products [107]. Standardised
cloning methods, like shotgun cloning or cDNA cloning [110], have been employed to express
exogenous genes or knockout native genes in Synechocystis 6803 [111–116]. For maximum expression
levels of heterologous genes, codon optimisation has been utilised in several studies with favorable
effects [16,116–118]. Additionally, the development of degradation tags used for the fine-tuning of
protein levels and protein turnover times in this model organism have also been achieved [100].
Such advances aid in the generation of more complex metabolic systems that have the potential to
oscillate in phase with circadian rhythms of cyanobacteria. Furthermore, recombinant DNA technology
has been employed in Synechocystis 6803 for the increased production of carotenoids [101]. In this
study, the psbAII promoter was used to drive the transcription and overexpression of coding sequence
of several genes involved in carotenoid biosynthesis. The genes cloned in Synechocystis 6803 were the
yeast isopentenyl diphosphate isomerase (ipi) and the Synechocystis β-carotene hydroxylase (crtR) and
the linked Synechocystis genes coding for phytoene desaturase and phytoene synthase (crtP and crtB,
respectively). The expression of ipi, crtR, and crtP and crtB led to a large increase in the corresponding
transcript levels that led to the accumulation of zeaxanthin and myxoxanthophyll in the mutant
strains [101]. A study involving increased production of carotenoids from Synechocystis 6803 reported
a β-phellandrene yield reaching 1% of the dry cell weight [116]. This was accomplished by expressing
β-phellandrene synthase as a fusion protein with the β-subunit of phycocyanin. The expression of
enzymes of the mevalonic acid (MVA) pathway and geranyl-diphosphate synthase (GPPS) increased
substrate availability and overall terpenoid biosynthesis pathway utilisation [116]. Another study
reported a pinene synthase mutant with an altered cofactor preference towards magnesium, which
possess superior activity to the wild-type [119]. Co-expression of a less active farnesyl-diphosphate
synthase (FPPS) increased production of pinene by allowing pinene synthase to outcompete FPPS for
GPP [119].
A quick way to create knockins and knockouts and introducing a trans-operon in cyanobacteria
was developed [108]. In this method, the open reading frames (ORF) for each desired protein are
codon optimised in silico for the chosen cyanobacterial chassis. The intergenic region sequences
identified in highly expressed native operons are then added to the sequences to create overlapping
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parts suitable for assembly where the synthesised parts are assembled in one step [108] into the
transformation vector, downstream of a regulatable promoter. The resulting plasmid is then used to
transform the chassis strain that contains a negative selectable marker (–ve) inserted into a neutral
locus. Two homologous recombination events allow replacement of the marker with the trans-operon,
with selection based on the loss of the marker, which results in a marker-less transgenic line. The
aim for using intergenic operon sequences taken directly from well-understood and highly expressed
operons within the host was to avoid internal transcriptional terminator sequences and to prevent
any self-hybridisation or secondary structure in mRNA transcripts. Expression of the trans-operon is
induced by a transcriptional activator encoded by a “regulator” gene in the chassis strain such that
inducer X (e.g., a metal ion) triggers production of the activator (Figure 2).
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Figure 2. Generation of marker-less mutants through homologous recombination using a codon
optimised trans-operon. Yellow boxes are the open reading frame (ORF). The green box is a gene used
as a negative marker (-ve). The purple circle is the activator that is produced by addition of inducer X.
Since the level and strength of gene expression is key for higher product titers, which is
of industrial biotechnology interest, a lot of attention has been directed to find ways to increase
expression of foreign genes in cyanobacteria. Current methods for the regulation of gene expression in
cyanobacteria include native and heterologous promoters that can be regulated by different inputs [26]
and the use of strong inducible promoters. The use of different types of inducible promoters in
cyanobacteria has been described in detail [29]. A list of inducible promoters that can be used in
cyanobacteria can be found in [29] and thus will not be discussed here. Recently, however, efficient
heterologous protein production from cyanobacteria was accomplished by utilizing a newly discovered
strong promoter (Pcpc560) [109]. The promoter consists of two predicted promoters from the cpcB gene
(sll1577) and 14 predicted transcription factor binding sites (TFBSs) that are crucial for its promotor
strength. It was found that using this promoter to express two genes, encoding enzymes involved
in metabolism in Synechocystis 6803 resulted in the buildup of functional proteins at a level of up to
15% of total soluble protein in the cyanobacterium. This level is comparable to that obtained using the
E. coli expression system, which demonstrated the strength and efficiency of Pcpc560. These findings
demonstrated the potential of utilizing Pcpc560 for the efficient production of recombinant proteins
in cyanobacteria.
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New methods for the precise regulation of gene expression became also available. For example,
theophylline-responsive riboswitches were utilised for the effective regulation of gene expression
in four diverse cyanobacterial species [12]. The riboswitches were evaluated for the expression of
a yellow fluorescent protein reporter in Synechococcus elongatus PCC 7942, Leptolyngbya sp. strain
BL0902, Anabaena sp. strain PCC 7120, and Synechocystis sp. strain WHSyn. The study demonstrated
that the riboswitches were effective and superior in regulating gene expression than the commonly
used isopropyl-β-D-thiogalactopyranoside induction of a lacIq-Ptrc promoter system. It has also been
shown that the new system can be used to regulate toxic genes (sacB), demonstrating the potential
of utilizing riboswitches to regulate proteins that are detrimental to biomass accumulation. Such
advancement in the field of synthetic biology and genetic engineering in diverse cyanobacteria facilitate
the development of microalgae bioengineering.
Another tool that has a particularly important industrial application is the development of gene
replacement methods that allow for the creation of antibiotic-free genetically modified cyanobacteria
(marker-less mutants) [101]. Such strains can be created using the toxic levanusucrase gene (sacB) [120]
that is illustrated in Figure 3. In addition to the sacB method, a more recent method of creating
marker-less mutants has been developed for and demonstrated in the model cyanobacterium
Synehcocystis. In this method, a mazF expression under the nickel-inducible, nrsB, promoter was
used [121]. The mazF gene, encodes an endoribonuclease that cleaves mRNA at the ACA triplet
sequence, inhibiting protein synthesis. To create the marker-less mutants, the nrsB promoter controls
expression of mazF gene and an antibiotic resistance cassette (in this case aphII encoding kanamycin
resistance was used) is also alongside the mazF gene (under the control of its own promoter). The
first selection was carried out on kanamycin, and the second selection on nickel. Attempts were later
directed towards reducing the number of cloning steps required to make marker-less transformants
using the sacB/nptI cassette [120]. Another marker-less mutant system for Synechocystis 6803 and
Synechoccocus elongatus PCC7942 was also developed using the FLP/FRT recombination system [122].
This system uses a self-replicable shutter that contains a flipase (FLP) gene from Saccharomyces cerevisiae,
which is introduced into the strains of Synechocystis 6803 and Synechoccocus 7942 where the genome
has already been transformed with a kanamycin resistance gene and a flipase recombination target
(FRT) flanking either side [122].
Life 2016, 6, 42 9 of 17 
 
used isopropyl-β-D-thiogalactopyranoside induction of a lacIq-Ptrc promoter system. It has also been 
shown that the new system can be used o regulate toxic genes (sacB), demonstrating the potential of 
utilizing riboswitches to regulate proteins that ar  detrimental to biomass a cumul tion. Such 
advancement in the field of synthetic biology and genetic engineering in diverse cyanobacteria 
facilitate the development of microalgae bioengineering. 
Another tool that has a particularly important industrial application is the development of gene 
replacement methods that allow for the creation of antibiotic-free genetically modified cyanobacteria 
(marker-less mutants) [101]. Such strains can be created using the toxic levanusucrase gene (sacB) 
[120] that is illustrated in Figure 3. In addition to the sacB method, a more recent method of creating 
marker-less mutants has been developed for and demonstrated in the model cyanobacterium 
Synehcocystis. In this metho ,  mazF expression u der the nickel-inducible, nrsB, promoter was used 
[121]. The mazF gene, codes an ndoribonuclease that cleaves mRNA at the ACA triplet sequence, 
i hibiting protein synthesi . To create the mark r-less mutants, the nrsB promot r controls expr ssion 
of mazF gene and an antibiotic resistance cassette (in this case aphII encoding kanamycin resistance 
was used) is also alongside the mazF gene (under the control of its own promoter). The first selection 
was carried out on kanamycin, and the second selection on nickel. Attempts were later directed 
towards reducing the number of cloning steps required to make marker-less transformants using the 
sacB/nptI cassette [120]. Another marker-less mutant system for Synechocystis 6803 and Synechoccocus 
elongatus PCC7942 was also developed using the FLP/FRT recombination system [122]. This system 
uses a self-replicable shutter that contains a flipase (FLP) gene from Saccharomyces cerevisiae, which is 
introduced into the strains of Synechocystis 6803 and Synechoccocus 7942 where the genome has 
already been transformed with a kanamycin resistance gene and a flipase re ombination ta get (FRT) 
flanking either side [122]. 
 
Figure 3. Generating marker-less mutants through consecutive insertion and deletion of sacB gene. 
The colors of the arrows and squares on each end are different to indicate the upstream and 
downstream regions of the selectable marker (SM) and sacB and that certain boxes match with certain 
arrows for recombination to occur. 
A novel system utilised for generating marker-less cyanobacterial mutants is CRISPR/Cas9 
[123,124]. CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR 
associated protein 9) was discovered in bacteria and archaea as an adaptive immune response to 
foreign DNA [125]. Initially, invader DNA is incorporated as a spacer, which is transcribed into RNA 
strands that direct the Cas9 protein to complimentary invader DNA to be cleaved [126]. By 
Figure 3. Generating marker-less mutants t h consecutive insertio and deletion of sacB gene.
The colors of the arrows and quares on ach end are diffe nt to indicate the upstream and dow stream
regions of the selectable marker (SM) and sacB and that certain boxes match with certain arrows for
recombination to occur.
Life 2016, 6, 42 10 of 17
A novel system utilised for generating marker-less cyanobacterial mutants is CRISPR/Cas9 [123,124].
CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR associated protein 9)
was discovered in bacteria and archaea as an adaptive immune response to foreign DNA [125].
Initially, invader DNA is incorporated as a spacer, which is transcribed into RNA strands that direct
the Cas9 protein to complimentary invader DNA to be cleaved [126]. By engineering the spacer
sequence to complement genetic targets, certain genes can be silenced or replaced with desired
sequences. The main advantage of using this method for marker-less mutant generation is the
ability to target several points for mutagenesis simultaneously [127–129]. There has been some work
aimed at characterizing native CRISPR systems in cyanobacteria [130–133], yet very limited work
on CRISPR/Cas9 application. A recent study has demonstrated that Cas9 is toxic to Synechococcus
elongatus UTEX 2973, yet marker-less mutants have been achieved through transient expression of the
Cas9 gene [123]. CRISPR interference (CRISPRi) has also been successful in the suppression of several
gene targets in cyanobacteria [124,134]. Although this system has not been applied on cyanobacterial
strains for a long time, its implementation for multiplex genome editing has potential of saving time
and effort.
5. Conclusions and Future Prospective
In the past decade, cyanobacterial research attracted a great deal of attention that has declined
recently due to biological restrictions of native strains at industrial-scale production [135]. This
has indicated that the use of cyanobacteria as an industrial platform requires the intervention of
genetic engineering. Due to advancements of synthetic biology tools and their implementation on
cyanobacterial organisms, a wide range of products have been achieved from direct CO2 conversion.
Most of the current work is focused on understanding cyanobacterial metabolic systems for tailoring
strains to be more resilient and productive. Advancements in sequencing technology that reduced cost
and increased output resulted in more cyanobacterial genomes being fully sequenced.
“Omic” studies that compare certain cyanobacterial strains with the model ones will shed light
on important factors that could accelerate progress of genetic engineering in these organisms. One
example is focusing research on discovering the cause behind the inability of certain cyanobacterial
strains to naturally transform with exogenous DNA, which could be enabled by incorporating a
competence gene, like comF of Synechocystis 6803 [136], or silencing certain nucleases genes. in silico
modeling, utilising flux balance analysis and systems biology, is a promising route for production
pathway optimisation of select strains [81]. This is valid for strains with well-annotated genomes,
like Synechocystis 6803, which makes achieving industrial-scale feasibility possible perhaps in the
“near” future.
The novel technique CRIPSR/Cas9 (clustered regularly interspaced short palindromic
repeats/CRISPR associated protein 9) has immensely advanced genomic editing of several organisms,
yet its implementation on cyanobacteria is still in early stages and more research is required to evaluate
the potential of this method. For industrial application, expression levels have to be enhanced for the
production process to generate acceptable profitability. Strong promoters, like Pcpc560, are essential
for good expression levels of desired products and thus further research is needed to test such strong
promoters on different cyanobacterial strains and production of different products. Introduction of
complete pathways for novel products could be possible in selected cyanobacterial strains by careful
evaluation and analysis of in silico models, exploitation of the CRISPR/Cas9 editing technique and the
use of a strong promoter.
The application of new genetic engineering tools on other cyanobacterial strains will expand
the platform of cyanobacterial use in industrial biotechnology. However, it is important to combine
genetic tools with other disciplines such as biochemistry in order to gain better understanding of
pathway engineering that may lead to novel industrial products or improve titers of existing ones.
Therefore, this combination should be done with a solid understanding of the microbial metabolism
at the system level in order to comprehend and overcome the effects of product toxicity that result
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from production and overexpression of novel products. Product excretion and removal from the
culture has successfully reduced the toxic effect of certain products [23,137,138]. Nevertheless,
research has to be directed towards a reliable method of transporting or excreting the products
with minimal effect on the health of the cells. Another idea of bypassing the toxic effect of products on
cyanobacterial cultures is by silencing certain stress response genes, specifically the ones responsible
for inducing apoptosis [139,140]. Better understanding of cyanobacterial metabolic systems along with
development of new genetic engineering tools will help tap into the great potential of cyanobacteria as
a multipurpose industrial “cell factory” of the future.
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